H. Lee Moffitt Cancer Center & Research Institute Inc-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8014344)
◆英語タイトル:H. Lee Moffitt Cancer Center & Research Institute Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014344
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:42
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
H. Lee Moffitt Cancer Center & Research Institute Inc (Moffitt) is a healthcare service provider that concentrates on the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services such as surgical care, fertility preservation, radiation therapy, interventional radiology, rehabilitation services, chemotherapy, cardio-oncology, blood and bone marrow transplant, cancer survivorship clinic, tumor board, interventional pain management, supportive care medicine, survivorship program, clinical trials, and others. It treats various types of cancers such as anal cancer, bladder cancer, brain cancer, breast cancer, colorectal cancer, esophageal cancer, gallbladder cancer and gastrointestinal carcinoid tumor, among others. Moffitt is headquartered in Tampa, Florida, the US.

H. Lee Moffitt Cancer Center & Research Institute Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
H. Lee Moffitt Cancer Center & Research Institute Inc, Medical Devices Deals, 2011 to YTD 2017 9
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
ITUS Enters into Agreement with Moffitt Cancer Center 12
Helix BioPharma and Moffitt Cancer Center Enter into Agreement 13
Vycellix Enters into Research Agreement with Moffitt Cancer Center 14
Lion Biotechnologies Enters into Research Agreement with H. Lee Moffitt Cancer Center and Research Institute 15
Incyte Enters into Agreement with Moffitt Cancer Center 16
Morphogenesis Enters into Agreement with Moffitt Cancer Center 17
Ignyta Enters into Research Agreement with Moffitt Cancer Center 18
HealthMyne Enters into Research Agreement with Moffitt Cancer Center 19
Lion Biotech Enters into Research Agreement with Lee Moffitt Cancer Center and Research Institute 20
Rosetta Genomics Enters into Co-Development Agreement with Moffitt Cancer Center 21
Moffitt Cancer Center Enters Into Agreement With Advinus For Target Cancer Therapies 22
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 23
H. Lee Moffitt Cancer Forms Joint Venture With US Oncology Network 24
Licensing Agreements 25
Lion Biotech Enters into Licensing Agreement wih Moffitt Cancer Center 25
Moffitt Cancer Center Enters into Licensing Agreement with Celgene 26
Moffitt Cancer Center Enters into Option for Licensing Agreement with Forma Therapeutics 27
Viteava Pharma Enters Into Licensing Agreement For Intellectual Property Portfolio Of Analogs And Derivatives 28
H. Lee Moffitt Cancer Center & Research Institute Inc – Key Competitors 30
H. Lee Moffitt Cancer Center & Research Institute Inc – Key Employees 31
H. Lee Moffitt Cancer Center & Research Institute Inc – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Government and Public Interest 34
Jun 12, 2017: Moffitt researchers identify inhibitor that overcomes drug resistance in prostate cancer 34
Jan 11, 2017: Moffitt researchers develop novel treatment to prevent graft-versus-host-disease 35
Jul 15, 2016: Moffitt Cancer Center Receives Two NCI Grants 36
Jul 08, 2016: Moffitt Researchers Find New Way to Control Genes Often Involved in Cancer Growth 37
May 13, 2016: Genetic biomarker may predict nerve pain side effects associated with prostate cancer treatment 38
Mar 17, 2016: Neutralizing a Tumor’s Acidic Environment Improves Activity of Immune-Targeting Cancer Therapies, Says Moffitt Cancer Center Researchers 39
Product News 40
Oct 12, 2017: 10 SU2C Catalyst Clinical Trials Launched 40
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Key Facts 2
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
H. Lee Moffitt Cancer Center & Research Institute Inc, Deals By Therapy Area, 2011 to YTD 2017 8
H. Lee Moffitt Cancer Center & Research Institute Inc, Medical Devices Deals, 2011 to YTD 2017 9
H. Lee Moffitt Cancer Center & Research Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
ITUS Enters into Agreement with Moffitt Cancer Center 12
Helix BioPharma and Moffitt Cancer Center Enter into Agreement 13
Vycellix Enters into Research Agreement with Moffitt Cancer Center 14
Lion Biotechnologies Enters into Research Agreement with H. Lee Moffitt Cancer Center and Research Institute 15
Incyte Enters into Agreement with Moffitt Cancer Center 16
Morphogenesis Enters into Agreement with Moffitt Cancer Center 17
Ignyta Enters into Research Agreement with Moffitt Cancer Center 18
HealthMyne Enters into Research Agreement with Moffitt Cancer Center 19
Lion Biotech Enters into Research Agreement with Lee Moffitt Cancer Center and Research Institute 20
Rosetta Genomics Enters into Co-Development Agreement with Moffitt Cancer Center 21
Moffitt Cancer Center Enters Into Agreement With Advinus For Target Cancer Therapies 22
Moffitt Cancer Center, Sanford-Burnham Medical Research Institute And Florida Hospital Enter Into Partnership To Form Personalized Medicine Partnership of Florida 23
H. Lee Moffitt Cancer Forms Joint Venture With US Oncology Network 24
Lion Biotech Enters into Licensing Agreement wih Moffitt Cancer Center 25
Moffitt Cancer Center Enters into Licensing Agreement with Celgene 26
Moffitt Cancer Center Enters into Option for Licensing Agreement with Forma Therapeutics 27
Viteava Pharma Enters Into Licensing Agreement For Intellectual Property Portfolio Of Analogs And Derivatives 28
H. Lee Moffitt Cancer Center & Research Institute Inc, Key Competitors 30
H. Lee Moffitt Cancer Center & Research Institute Inc, Key Employees 31
H. Lee Moffitt Cancer Center & Research Institute Inc, Subsidiaries 33

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ H. Lee Moffitt Cancer Center & Research Institute Inc-製薬・医療分野:企業M&A・提携分析(H. Lee Moffitt Cancer Center & Research Institute Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆